Company Filing History:
Years Active: 2021
Title: I-Chieh Wang: Innovator in Antibody Development
Introduction
I-Chieh Wang is a prominent inventor based in San Bruno, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for viral infections. With a total of 6 patents, his work is at the forefront of medical innovation.
Latest Patents
Wang's latest patents include groundbreaking research on Anti-SARS-CoV-2 antibodies derived from 6nb6. This disclosure provides antibodies and antigen-binding fragments that can be administered to individuals infected or suspected of being infected with the virus. These antibodies are capable of treating or curing the virus and may offer protection for several weeks. Additionally, they can be utilized to diagnose a SARS-CoV-2 infection. Another significant patent involves Anti-SARS-CoV-2 antibodies derived from CR3022, which also provides similar therapeutic and diagnostic capabilities.
Career Highlights
I-Chieh Wang is currently associated with Centivax, Inc., where he continues to push the boundaries of antibody research. His innovative work has the potential to impact public health significantly, especially in the context of viral outbreaks.
Collaborations
Wang collaborates with notable colleagues such as Jacob Glanville and Shahrad Daraeikia, contributing to a dynamic research environment focused on advancing therapeutic solutions.
Conclusion
I-Chieh Wang's contributions to antibody development exemplify the critical role of inventors in addressing global health challenges. His innovative patents and ongoing research are paving the way for effective treatments against viral infections.